Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? Stefan WalentaThe-Van ChauWolfgang Mueller-Klieser Original Paper 25 June 2003 Pages: 321 - 326
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts Wei-Dong JiaGe-Liang XuQiong Xue Original Paper 14 June 2003 Pages: 327 - 334
High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazine Hiroki SakaiTetsuya TsukamotoMasae Tatematsu Original Paper 13 May 2003 Pages: 335 - 340
Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells Wei XiangPauline WimbergerRainer Kimmig Original Paper 18 June 2003 Pages: 341 - 348
Analysis of DLC-1 expression in human breast cancer Marlies PlaumannSusanne SeitzSiegfried Scherneck Original Paper 21 May 2003 Pages: 349 - 354
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma Masahiro MunakaKiyotaka KohshiTakahiko Katoh Original Paper 21 May 2003 Pages: 355 - 360
Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer Herbert G. SayerKristina SchillingKlaus Höffken Original Paper 18 June 2003 Pages: 361 - 366
Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells Satoshi OkabeTakehiro AraiKenichi Sugihara Original Paper 03 June 2003 Pages: 367 - 373